Back to Search
Start Over
Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL.
- Source :
-
Leukemia [Leukemia] 2024 Jan; Vol. 38 (1), pp. 226. - Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 1476-5551
- Volume :
- 38
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Leukemia
- Accession number :
- 38036631
- Full Text :
- https://doi.org/10.1038/s41375-023-02090-w